U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07848737) titled 'A Real-World Study of Guselkumab Persistence and Effectiveness in Participants With Crohn's Disease or Ulcerative Colitis' on Sept. 24.
Brief Summary: The purpose of this study is to evaluate how long participants with moderate-to-severe Crohn's Disease (CD) and Ulcerative Colitis (UC) continue treatment with guselkumab in a real-world setting. CD and UC are long-term diseases that cause inflammation in intestine (part of digestive system).
Study Start Date: Oct. 30
Study Type: OBSERVATIONAL
Condition:
Colitis, Ulcerative
Crohn Disease
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Janssen-Cilag, S.A.
Published by HT Digital ...